Pulling SEC filings + quote and writing the call…

FutureFuel Corp.
Next earnings Aug 10, 2026
Last earnings -1.2% on 2026-05-11
Revenue halved, gross margin turned negative, and the whole thesis hinges on an unfinalized federal biodiesel credit — uninvestable now.
Revenue $95.7M · FY2025
FutureFuel has gone from a profitable, cash-generative specialty-chemicals-plus-biodiesel operator to a business that can't cover its own cost of goods. FY2025 revenue collapsed 60.7% to $95.7M (from $243M in FY2024 and $368M in FY2023), and every profitability line went red: gross profit -$39.4M (-41.2% margin), operating income -$53.0M, net income -$49.4M versus +$15.5M a year earlier. A negative gross margin is the tell — the company is losing money before any overhead, exactly the scenario the 10-K flags where 'if biodiesel prices decrease... and biodiesel feedstock costs do not decrease proportionately, we could realize a negative gross margin on biodiesel' and 'could be forced to cease production.' Operating cash flow of -$28.7M against $17.2M of capex means real burn, and the dividend was cut 91% to $10.5M — a clear signal management is defending liquidity.
The root cause is regulatory, and the filing is explicit that it is unresolved. The $1.00/gal Blenders Tax Credit (BTC) expired December 31, 2024 and its replacement, the Clean Fuel Production Credit (CFPC), is still only in 'proposed rule status,' with guidance issued February 3, 2026 and finalization not expected until mid-2026. Management concedes the CFPC's headline $1.00 credit 'would require zero GHG emissions which is unrealistic for almost every biodiesel producer, including the Company.' Layer on delayed RFS2 volume obligations depressing RIN values (RIN inventory fell from 3.1M units worth $1,831K to just 0.4M worth $379K), and structural headwinds from renewable diesel (1.7 vs 1.5 equivalency) and EV policy, and the forward earnings picture is genuinely unknowable — not merely weak.
Is FF a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $321M | $396M | $368M | $243M | $95.7M |
| Gross profit | $23.5M | $29.0M | $41.0M | $19.6M | -$39.4M |
| Operating income | $12.9M | $17.5M | $27.4M | $6.37M | -$53.0M |
| Net income | $26.3M | $15.2M | $37.4M | $15.5M | -$49.4M |
| Diluted EPS | $0.60 | $0.35 | $0.85 | $0.35 | -$1.13 |
| Net margin | 8.2% | 3.8% | 10.2% | 6.4% | -51.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 8.01 other-events disclosure; routine corporate update, no financial results
Item 5.02 officer/director change disclosed; leadership transition
Q1'26 10-Q: biodiesel headwinds continue as CFPC rules stay unfinalized
Q1'26 10-Q: biodiesel headwinds continue as CFPC rules stay unfinalized
Item 8.01 other-events disclosure; routine, no results
Item 8.01 other-events disclosure (dividend/general update)
FY2025 10-K: revenue -61% to $96M, $49M loss, dividend slashed 91%
FY2025 10-K: revenue -61% to $96M, $49M loss, dividend slashed 91%
Q3'25 10-Q: biodiesel margins deteriorate on BTC expiry/RIN uncertainty
Sources: SEC EDGAR (CIK 0001337298, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 7/3/2026, 11:28:02 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 7:28 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 0 sales
| 2026-06-04 | Polet Roeland Chief Executive Officer | Buy | 10.0K @ $4.28 | $42.8K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median